HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$15.53
Day range
$14.10 - $15.70
Year range
$11.43 - $27.20
Market cap
1.14B USD
Avg Volume
956.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 72.00K | 0.00% |
Operating expense | 15.58M | -52.76% |
Net income | -79.72M | -19.24% |
Net profit margin | -110.73K | -19.24% |
Earnings per share | -0.81 | 40.00% |
EBITDA | -87.34M | -22.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 753.24M | 57.79% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 707.50M | — |
Shares outstanding | 80.99M | — |
Price to book | 2.37 | — |
Return on assets | — | — |
Return on capital | -29.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -79.72M | -19.24% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2010
Headquarters
Website
Employees
96
